Volume 12 Issue 2
Mar.  2021
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2021  >  12(2): 203-208
Wen Huanshun, Hao Yang, Chen Jingyu, et al. Analysis of risk factors and clinical prognosis of massive blood transfusion during perioperative period of lung transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(2): 203-208. doi: 10.3969/j.issn.1674-7445.2021.02.011
Citation: Wen Huanshun, Hao Yang, Chen Jingyu, et al. Analysis of risk factors and clinical prognosis of massive blood transfusion during perioperative period of lung transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(2): 203-208. doi: 10.3969/j.issn.1674-7445.2021.02.011
shu

Analysis of risk factors and clinical prognosis of massive blood transfusion during perioperative period of lung transplantation

doi: 10.3969/j.issn.1674-7445.2021.02.011

  • Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing 100029, China

More Information
    Abstract
  •   Objective  To investigate the risk factors and clinical prognosis of massive blood transfusion during the perioperative period of lung transplantation.  Methods  Clinical data of 159 lung transplant recipients were retrospectively analyzed. According to the quantity of perioperative blood transfusion, all recipients were divided into the massive blood transfusion group (n=20) and non-massive blood transfusion group (n=139). Clinical data of lung transplant recipients were statistically compared between two groups. The risk factors of perioperative massive blood transfusion were analyzed. Clinical prognosis of the recipients was observed in two groups.  Results  There were significant differences between the two groups in preoperative data including anticoagulant therapy, hemoglobin content, the number of recipents with idiopathic pulmonary fibrosis or idiopathic pulmonary hypertension, and intraoperative data including the number of recipents presenting with intraoperative intrathoracic adhesion, operation time and the amount of various component transfusion(all P < 0.05). Preoperative anticoagulant therapy, incidence of intraoperative intrathoracic adhesion, use of extracorporeal membrane oxygenation (ECMO) and long operation time were the risk factors of massive blood transfusion during perioperative period of lung transplantation(all P < 0.05). In the massive blood transfusion group, the incidence rate of grade Ⅲ primary graft dysfunction (PGD) and the fatality within postoperative 30 d were higher compared with those in the non-massive blood transfusion group(both P < 0.01). Low body mass index (BMI) and massive blood transfusion were the risk factors for death within postoperative 30 d(P=0.048、P < 0.001). The 1-year survival rate in the massive blood transfusion group was lower than that in the non-massive blood transfusion group(P < 0.001).  Conclusions  Preoperative anticoagulant therapy, incidence of intraoperative intrathoracic adhesion, use of ECMO and long operation time are the risk factors for massive blood transfusion during perioperative period of lung transplantation. Massive blood transfusion negatively affects the clinical prognosis of the recipients undergoing lung transplantation.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    THABUT G, MAL H. Outcomes after lung transplantation[J]. J Thorac Dis, 2017, 9(8): 2684-2691. DOI: 10.21037/jtd.2017.07.85.
    [2]
    MONTGOMERY E, MACDONALD PS, NEWTON PJ, et al. Frailty in lung transplantation: a systematic review[J]. Expert Rev Respir Med, 2020, 14(2): 219-227. DOI: 10.1080/17476348.2020.1702527.
    [3]
    AHYA VN, DIAMOND JM. Lung Transplantation[J]. Med Clin North Am, 2019, 103(3): 425-433. DOI: 10.1016/j.mcna.2018.12.003.
    [4]
    江文洋, 耿庆, 王博, 等. 单中心肺移植围手术期治疗经验总结[J]. 临床外科杂志, 2020, 28(3): 247-249. DOI: 10.3969/j.issn.1005-6483.2020.03.016.

    JIANG WY, GENG Q, WANG B, et al. Experience of perioperative treatment of lung transplantation in a single institute[J]. J Clin Surg, 2020, 28(3): 247-249. DOI: 10.3969/j.issn.1005-6483.2020.03.016.
    [5]
    MAEGELE M. Challenges to improving patient outcome following massive transfusion in severe trauma[J]. Expert Rev Hematol, 2020, 13(4): 323-330. DOI: 10.1080/17474086.2020.1733404.
    [6]
    PHAM HP, SHAZ BH. Update on massive transfusion[J]. Br J Anaesth, 2013, 111(Suppl 1): i71-i82. DOI10.1093/bja/aet376. doi: 10.1093/bja/aet376
    [7]
    OECHSLIN P, ZALUNARDO MP, INCI I, et al. Established and potential predictors of blood loss during lung transplant surgery[J]. J Thorac Dis, 2018, 10(6): 3845-3848. DOI: 10.21037/jtd.2018.05.165.
    [8]
    KARKOUTI K, WIJEYSUNDERA DN, YAU TM, et al. The independent association of massive blood loss with mortality in cardiac surgery[J]. Transfusion, 2004, 44(10): 1453-1462. DOI: 10.1111/j.1537-2995.2004. 04144.x.
    [9]
    CERNAK V, OUDE LANSINK-HARTGRING A, VAN DEN HEUVEL ER, et al. Incidence of massive transfusion and overall transfusion requirements during lung transplantation over a 25-year period[J]. J Cardiothorac Vasc Anesth, 2019, 33(9): 2478-2486. DOI: 10.1053/j.jvca.2019.03.060.
    [10]
    KEELING D, TAIT RC, WATSON H, et al. Peri-operative management of anticoagulation and antiplatelet therapy[J]. Br J Haematol, 2016, 175(4): 602-613. DOI: 10.1111/bjh.14344.
    [11]
    LEVY JH, KOSTER A, QUINONES QJ, et al. Antifibrinolytic therapy and perioperative considerations[J]. Anesthesiology, 2018, 128(3): 657-670. DOI: 10.1097/ALN.0000000000001997.
    [12]
    毛文君, 陈静瑜. 中国肺移植面临的困难及对策[J/CD]. 中华胸部外科电子杂志, 2016, 3(1): 1-6. DOI: 10.3877/cma.j.issn.2095-8773.2016.01.001.

    MAO WJ, CHEN JY. Difficulties and countermeasures of lung transplantation in China[J/CD]. Chin J Thorac Surg (Electr Edit), 2016, 3(1): 1-6. DOI: 10.3877/cma.j.issn.2095-8773.2016.01.001.
    [13]
    YU WS, PAIK HC, HAAM SJ, et al. Transition to routine use of venoarterial extracorporeal oxygenation during lung transplantation could improve early outcomes[J]. J Thorac Dis, 2016, 8(7): 1712-1720. DOI: 10.21037/jtd.2016.06.18.
    [14]
    杨柯佳, 毛文君, 陈静瑜. 体外膜肺氧合作为肺移植术前移植桥梁的研究进展[J]. 器官移植, 2019, 10(2): 202-205. DOI: 10.3969/j.issn.1674-7445.2019.02.015.

    YANG KJ, MAO WJ, CHEN JY. Research progress on extracorporeal membrane oxygenation as a transplantation bridge before lung transplantation[J]. Organ Transplant, 2019, 10(2): 202-205. DOI: 10.3969/j.issn.1674-7445.2019.02.015.
    [15]
    AUBRON C, CHENG AC, PILCHER D, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study[J]. Crit Care, 2013, 17(2): R73. DOI: 10.1186/cc12681.
    [16]
    SMITH I, PEARSE BL, FAULKE DJ, et al. Targeted bleeding management reduces the requirements for blood component therapy in lung transplant recipients[J]. J Cardiothorac Vasc Anesth, 2017, 31(2): 426-433. DOI: 10.1053/j.jvca.2016.06.027.
    [17]
    MAGOULIOTIS DE, TASIOPOULOU VS, SVOKOS AA, et al. Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a Meta-analysis[J]. Gen Thorac Cardiovasc Surg, 2018, 66(1): 38-47. DOI: 10.1007/s11748-017-0836-3.
    [18]
    CHAMBERS DC, YUSEN RD, CHERIKH WS, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time[J]. J Heart Lung Transplant, 2017, 36(10): 1047-1059. DOI: 10.1016/j.healun.2017.07.016.
    [19]
    徐鑫, 陈汉章, 韦兵, 等. 肺移植治疗终末期肺疾病的单中心十年经验总结[J]. 中华器官移植杂志, 2013, 34(3): 155-158. DOI: 10.3760/cma.j.issn.0254-1785.2013.03.008.

    XU X, CHEN HZ, WEI B, et al. Lung transplantation for end-stage lung diseases: a 10-year experience in single center[J]. Chin J Organ Transplant, 2013, 34(3): 155-158. DOI: 10.3760/cma.j.issn.0254-1785.2013.03.008.
    [20]
    陈乾坤, 姜格宁, 何文新, 等. 42例肺移植单中心8年临床经验总结[J]. 中华胸心血管外科杂志, 2011, 27(10): 594-596. DOI: 10.3760/cma.j.issn.1001-4497.2011.010.006.

    CHEN QK, JIANG GN, HE WX, et. al. Lung transplantation in 42 cases: an 8-year experience in a single center[J]. Chin J Thorac Cardiovasc Surg, 2011, 27(10): 594-596. DOI: 10.3760/cma.j.issn.1001-4497.2011.010.006.
    [21]
    WEBER D, COTTINI SR, LOCHER P, et al. Association of intraoperative transfusion of blood products with mortality in lung transplant recipients[J]. Perioper Med (Lond), 2013, 2(1): 20. DOI: 10.1186/2047-0525-2-20.
    [22]
    ONG LP, THOMPSON E, SACHDEVA A, et al. Allogeneic blood transfusion in bilateral lung transplantation: impact on early function and mortality[J]. Eur J Cardiothorac Surg, 2016, 49(2): 668-674. DOI: 10.1093/ejcts/ezv155.
    [23]
    纪勇, 陈静瑜, 郑明峰, 等. 肺移植术后早期原发性移植物失功的危险因素与防治[J]. 中华胸心血管外科杂志, 2017, 33(12): 738-742. DOI:10.3760/cma.j.issn.1001- 4497.2017.12.009.

    JI Y, CHEN JY, ZHENG MF, et al. Clinical analysis of risk factors for early primary graft dysfunction after lung transplantation[J]. Chin J Thorac Cardiovasc Surg, 2017, 33(12): 738-742. DOI:10.3760/cma.j.issn.1001-4497. 2017.12.009.
    [24]
    AVTAAR SINGH SS, BANNER NR, RUSHTON S, et al. ISHLT primary graft dysfunction incidence, risk factors, and outcome: a UK national study[J]. Transplantation, 2019, 103(2): 336-343. DOI: 10.1097/TP.0000000000002220.
    [25]
    李基伟, 徐磊, 韩志军, 等. 肺移植术后原发性移植功能障碍风险因素的logistic回归分析[J]. 中华医学杂志, 2018, 98(19): 1503-1506. DOI: 10.3760/cma.j.issn.0376-2491.2018.19.010.

    LI JW, XU L, HAN ZJ, et. al. Logistic regression analysis of risk factors for primary graft dysfunction after lung transplantation[J]. Natl Med J China, 2018, 98(19): 1503-1506. DOI: 10.3760/cma.j.issn.0376-2491.2018.19.010.
    [26]
    GRIES CJ, BHADRIRAJU S, EDELMAN JD, et al. Obese patients with idiopathic pulmonary fibrosis have a higher 90-day mortality risk with bilateral lung transplantation[J]. J Heart Lung Transplant, 2015, 34(2): 241-246. DOI: 10.1016/j.healun.2014.09.031.
    [27]
    SINGER JP, PETERSON ER, SNYDER ME, et al. Body composition and mortality after adult lung transplantation in the United States[J]. Am J Respir Crit Care Med, 2014, 190(9): 1012-1021. DOI: 10.1164/rccm.201405-0973OC.
    [28]
    UPALA S, PANICHSILLAPAKIT T, WIJARNPREECHA K, et al. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and Meta-analysis[J]. Transpl Int, 2016, 29(3): 285-296. DOI: 10.1111/tri.12721.
    [29]
    RUSSO MJ, DAVIES RR, HONG KN, et al. Who is the high-risk recipient? predicting mortality after lung transplantation using pretransplant risk factors[J]. J Thorac Cardiovasc Surg, 2009, 138(5): 1234-1238. DOI: 10.1016/j.jtcvs.2009.07.036.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (324) PDF downloads(34) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return